Mimedx (MDXG) Retained Earnings (2010 - 2026)

Mimedx has disclosed Retained Earnings across 17 years of filings, most recently posting $297.1 million for Q2 2026.

• In Q2 2026, Retained Earnings rose 2.06% year-over-year to $297.1 million; the TTM figure through Jun 2026 stood at $297.1 million (up 2.06% YoY), while the FY2025 annual figure was $299.1 million, up 5.23% from the prior year.
• Retained Earnings came in at $297.1 million for Q2 2026 at Mimedx, roughly flat from $296.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $299.1 million in Q4 2025 to a low of -$196.9 million in Q1 2023.
• Average Retained Earnings over 5 years is $123.3 million, with a median of $277.9 million recorded in 2023.
• Year-over-year, Retained Earnings slumped 215.82% in 2022 and surged 243.95% in 2023.
• Over 5 years, Retained Earnings stood at -$191.9 million in 2022, then surged by 243.95% to $276.2 million in 2023, then rose by 2.89% to $284.2 million in 2024, then rose by 5.23% to $299.1 million in 2025, then slipped by 0.66% to $297.1 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $297.1 million in Q2 2026, $296.3 million in Q1 2026, and $299.1 million in Q4 2025.